Navigation Links
Bacchus Vascular Names Scott Cramer as President and CEO
Date:10/16/2007

Experienced Sales Executive to Lead Growing Medical Device Firm

SANTA CLARA, Calif., Oct. 16 /PRNewswire/ -- Bacchus Vascular Inc., a leading provider of innovative medical devices used by interventional radiologists and vascular surgeons for the minimally invasive treatment of deep vein thrombosis (DVT) and other peripheral vascular disease, announced today that it has named Scott Cramer to the position of President and Chief Executive Officer.

Mr. Cramer joined Bacchus Vascular earlier this year as Senior Vice President of Sales. Previously he served as Senior Vice President of U.S. Sales and Account Services for VNUS Medical Technologies (Nasdaq: VNUS) from 2000 until April, 2007. Prior to that, Mr. Cramer held senior management positions with EndoSonics Corporation and Cardiometrics, Inc., as well as management positions with Baxter Healthcare Corporation's cardiovascular division. Mr. Cramer holds a B.S. degree in Finance from the Philadelphia University.

"Scott Cramer has a broad background in the vascular disease and interventional field, a strong track record of introducing innovative medical technologies, and proven success developing new markets," said Elizabeth H. (Bess) Weatherman, Managing Director, Healthcare - Medical Devices for Warburg Pincus LLC, and a Director of Bacchus Vascular.

"Scott brings a wealth of experience to Bacchus Vascular, and we look forward to his leadership in the next phase of the Company's growth," added Thomas Fogarty, MD, Chairman of the Board of Bacchus Vascular.

The Company's previous President and CEO, R. Scott Rader, is relocating to the east coast to fulfill family obligations and pursue other business opportunities. He will remain on the Board of Directors of Bacchus Vascular.

"Scott Rader successfully led Bacchus Vascular through three years of product development, market introduction and clinical success with the Trellis device. We are grateful for his skilled leadership during this stage of the Company's development and are pleased that he will be remaining on the Board of Directors," said Dr. Fogarty.

About Bacchus Vascular

Bacchus Vascular, Inc. is a privately-held medical device company dedicated to the treatment of peripheral vascular disease. Dr. Thomas Fogarty, a noted inventor and cardiovascular surgeon, founded the company with the vision of transforming blood clot removal from peripheral blood vessels into a fast, simple, minimally-invasive catheter-based procedure. Thousands of patients suffering from DVT and other occlusive vascular diseases have been treated worldwide to date using the company's Trellis(R) Peripheral Infusion System and other products.

For more information, visit http://www.bacchusvascular.com.


'/>"/>
SOURCE Bacchus Vascular Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. “Don’t fear long haul flights!” Vascular surgeon tells travelrs
2. People who fight wars may be at high risk of cardiovascular disease
3. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
4. High iron levels may cause Cardiovascular Disease in women
5. Erectile dysfunction (ED) signals vascular disease
6. Drug Effective for Vascular Dementia
7. Air Pollution said To Increase Risk of Cardiovascular Disease
8. Link Between Alcohol Consumption And Cardiovascular Disease
9. Beer Found To Be Effective In Fighting Cardiovascular Disease
10. New Guidelines Found To Benefit Cardiovascular Treatment
11. Women With A High-Risk Of Cardiovascular Disease Under treated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
Breaking Medicine Technology: